Petmed Express Inc
NASDAQ:PETS

Watchlist Manager
Petmed Express Inc Logo
Petmed Express Inc
NASDAQ:PETS
Watchlist
Price: 4.84 USD -0.62% Market Closed
Market Cap: 100m USD
Have any thoughts about
Petmed Express Inc?
Write Note

Petmed Express Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Petmed Express Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Petmed Express Inc
NASDAQ:PETS
Cash & Cash Equivalents
$52m
CAGR 3-Years
-21%
CAGR 5-Years
-11%
CAGR 10-Years
4%
D
DoorDash Inc
NASDAQ:DASH
Cash & Cash Equivalents
$2.7B
CAGR 3-Years
-15%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Chewy Inc
NYSE:CHWY
Cash & Cash Equivalents
$694.5m
CAGR 3-Years
-1%
CAGR 5-Years
36%
CAGR 10-Years
N/A
ETSY Inc
NASDAQ:ETSY
Cash & Cash Equivalents
$818.9m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
28%
eBay Inc
NASDAQ:EBAY
Cash & Cash Equivalents
$1.6B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
-10%
Amazon.com Inc
NASDAQ:AMZN
Cash & Cash Equivalents
$75.1B
CAGR 3-Years
36%
CAGR 5-Years
26%
CAGR 10-Years
30%
No Stocks Found

Petmed Express Inc
Glance View

Market Cap
100m USD
Industry
Retail

PetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The company is headquartered in Delray Beach, Florida and currently employs 212 full-time employees. The company went IPO on 2000-04-06. The firm's product line contains approximately 3,000 SKUs of pet medications, health products, and supplies. The company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. The firm's products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

PETS Intrinsic Value
6.53 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Petmed Express Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
52m USD

Based on the financial report for Sep 30, 2024, Petmed Express Inc's Cash & Cash Equivalents amounts to 52m USD.

What is Petmed Express Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
4%

Over the last year, the Cash & Cash Equivalents growth was -3%. The average annual Cash & Cash Equivalents growth rates for Petmed Express Inc have been -21% over the past three years , -11% over the past five years , and 4% over the past ten years .

Back to Top